Area(s) of Specialization/Research Interests
Medical Microbiology
Profile
Therapeutic options available for Methicillin Resistant Staphylococcus aureus (MRSA) infections are limited because MRSA has acquired resistance to multiple antibiotic classes. I am thus interested in identifying novel treatment options for the treatment of infections caused by MRSA as well as bacteria of public health importance.
Academic Credentials
PhD Molecular Medicine (Medical Microbiology): March 2020 MSc Bioscience (Infection and Immunity): November 2011 BSc (Hons) Microbiology: January 2008 West African Examinations Council Result: June 2000
Professional Association
Publications
| 1 | Fayemi, O. E., Elegbeleye, J. A., Akanni, G. B., Olaleye, E. D., Ogunremi, O. R., Kaindi, D. W., Okunbi, F. O. and Ayansi, J. A. (2023) ‘Bioactive phytochemicals in the development of alternative medicine’, in Onuh, J. O. and Pathak, Y. V. (eds), Plant food phytochemicals and bioactive compounds in nutrition and health, CRC Press (In press)-Updated on: 17Jan24 | |
|---|---|---|
| 2 | Li, J., Olaleye, E., Kong, X., Zhou, T., Ma, Y., Jurach, J., Al Rugaie, O., Hider, R. C., Zhang, G., Alsam, S. and Abbate, V. (2016) ‘Macromolecular iron-chelators via RAFT-polymerisation for the inhibition of methicillin-resistant Staphylococcus aureus growth’, Polymer, 87, 64-72-Updated on: 17Jan24 |